MedPath

A bioequivalence study of single oral dose of three brands of 300mg Phenytoin sodium tablets marketed in India, on healthy Indian human volunteers

Phase 4
Completed
Registration Number
CTRI/2011/05/001709
Lead Sponsor
Abbott India Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

?Weight range within 20% of the ideal body weight as per standard tables and Indian criteria.

?Age 18-45 years of male gender only.

?Patients willing to sign informed consent form before undergoing screening.

?Patients willing to undergo follow up for 2 ? 6 months.

?Physical examination ? all findings of physical examination are normal with no ongoing serious illness that may affect the outcome of the study.

?Biochemical and hematologic test values (done within 2 week of the study), urine examination, and ECG?all within normal limit

?Negative for Hbs Ag (Australia antigen) and HIV

?Agreement to abstain from caffeine on the day of the study and from alcohol and any other medication for 48 hours prior to entry into the study and during the course of the study

Exclusion Criteria

?History of intercurrent or concurrent diseases chronic alcohol consumption or drug addiction.

?History of chronic GI, renal, hepatic, cardiovascular, CNS, respiratory, infectious, or psychiatric diseases that affect the outcome of the study,

?History of allergy or hypersensitivity to phenytoin sodium, consumption of tobacco in any form, participation in a new drug study in the past 6 months and in a bioavailability or any study of a marketed drug in the past 3 months, donating blood in the past 3 months,

?Any drug intake in the past 15 days or intake of an enzyme-inducing agent in the past 30 days.

Study & Design

Study Type
BA/BE
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To calculate pharmacokinetic parameters such as Cmax, tmax, AUC0-t and compare it with comparator drugsTimepoint: blood will be collected at 0,1,2,3,4,5,6,8,10,12,24,36,48,60 and 72 hours and parameters will be collected at these time points
Secondary Outcome Measures
NameTimeMethod
nilTimepoint: nil
© Copyright 2025. All Rights Reserved by MedPath